Published in J Cardiothorac Vasc Anesth on June 02, 2013
Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the RIFLE classification. BMC Nephrol (2015) 0.87
Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria. BMC Nephrol (2017) 0.75
Long-Term Risk of Progressive Chronic Kidney Disease in Patients with Severe Acute Kidney Injury Requiring Dialysis after Coronary Artery Bypass Surgery. Cardiorenal Med (2015) 0.75
Meta-analysis for outcomes of acute kidney injury after cardiac surgery. Medicine (Baltimore) (2016) 0.75
Fluid balance, change in serum creatinine and urine output as markers of acute kidney injury post cardiac surgery: an observational study. Can J Kidney Health Dis (2014) 0.75
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology (2006) 3.66
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial. J Am Coll Cardiol (2006) 2.88
Neutrophil gelatinase-associated lipocalin combined with delta serum creatinine provides early risk stratification for adverse outcomes after cardiac surgery: a prospective observational study. Crit Care Med (2015) 2.04
Determination of brain death by apnea test adapted to extracorporeal cardiopulmonary resuscitation. J Cardiothorac Vasc Anesth (2012) 1.98
Mechanisms of atrial tachyarrhythmias following surgical atrial fibrillation ablation. J Cardiovasc Electrophysiol (2006) 1.71
Clinical and economic burden of postoperative pulmonary complications: patient safety summit on definition, risk-reducing interventions, and preventive strategies. Crit Care Med (2011) 1.70
Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation (2006) 1.62
Effect of donor age on long-term survival following cardiac transplantation. J Card Surg (2006) 1.54
Clevidipine compared with nitroglycerin for blood pressure control in coronary artery bypass grafting: a randomized double-blind study. Can J Anaesth (2014) 1.52
Incidence and predictors of pacemaker placement after surgical ablation for atrial fibrillation. Ann Thorac Surg (2011) 1.52
A comparison of atrial arrhythmias after heart or double-lung transplantation at a single center: insights into the mechanism of post-operative atrial fibrillation. J Am Coll Cardiol (2009) 1.51
Laser energy source in surgical atrial fibrillation ablation: preclinical experience. Ann Thorac Surg (2006) 1.47
Long-term outcomes with a minimally invasive approach for resection of cardiac masses. Ann Thorac Surg (2010) 1.45
Coronary artery bypass grafting in patients with low ejection fraction. Circulation (2005) 1.36
The golden age of minimally invasive cardiothoracic surgery: current and future perspectives. Future Cardiol (2011) 1.32
Robotic techniques improve quality of life in patients undergoing atrial septal defect repair. Ann Thorac Surg (2004) 1.29
Minimally invasive versus sternotomy approach for mitral valve surgery: a propensity analysis. Ann Thorac Surg (2010) 1.23
Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg (2003) 1.19
Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg (2011) 1.17
Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists. Crit Care Clin (2009) 1.14
Posttransplant survival is not diminished in heart transplant recipients bridged with implantable left ventricular assist devices. J Thorac Cardiovasc Surg (2009) 1.14
A minimally invasive approach is more cost-effective than a traditional sternotomy approach for mitral valve surgery. J Thorac Cardiovasc Surg (2011) 1.11
Guidelines for critical care medicine training and continuing medical education. Crit Care Med (2004) 1.11
Dexmedetomidine in the care of critically ill patients from 2001 to 2007: an observational cohort study. Anesthesiology (2010) 1.08
Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral Mu antagonists. Anesthesiol Clin (2011) 1.08
Does robotic technology make minimally invasive cardiac surgery too expensive? A hospital cost analysis of robotic and conventional techniques. J Card Surg (2005) 1.07
Risk analysis of deep sternal wound infections and their impact on long-term survival: a propensity analysis. Ann Plast Surg (2008) 1.06
Preventing acute kidney injury after cardiac surgery. Curr Opin Anaesthesiol (2011) 1.05
Comparative effectiveness of minimally invasive versus traditional sternotomy mitral valve surgery in elderly patients. J Thorac Cardiovasc Surg (2012) 1.03
Retracted Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery. J Clin Anesth (2006) 1.02
Matching high-risk recipients with marginal donor hearts is a clinically effective strategy. Ann Thorac Surg (2009) 1.02
Evolution of cannulation techniques for minimally invasive cardiac surgery: a 10-year journey. Innovations (Phila) (2012) 1.02
The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg (2007) 1.00
Endoscopic computer-enhanced mediastinal mass resection using robotic technology. Heart Surg Forum (2003) 0.98
Association between having a caregiver and clinical outcomes 1 year after hospitalization for cardiovascular disease. Am J Cardiol (2011) 0.98
Quality, not volume, determines outcome of coronary artery bypass surgery in a university-based community hospital network. J Thorac Cardiovasc Surg (2011) 0.97
Acute kidney injury in cardiac surgery. Curr Opin Anaesthesiol (2015) 0.94
Del Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison. J Cardiothorac Surg (2014) 0.93
Designing comparative effectiveness trials of surgical ablation for atrial fibrillation: experience of the Cardiothoracic Surgical Trials Network. J Thorac Cardiovasc Surg (2011) 0.92
A decade experience of cardiac retransplantation in adult recipients. J Heart Lung Transplant (2005) 0.89
Endoscopic, robotically assisted implantation of phrenic pacemakers. J Thorac Cardiovasc Surg (2003) 0.89
Effect of epicardial fat on ablation performance: a three-energy source comparison. J Card Surg (2007) 0.88
EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. J Thorac Cardiovasc Surg (2012) 0.88
Right atrial lesions do not improve the efficacy of a complete left atrial lesion set in the surgical treatment of atrial fibrillation, but they do increase procedural morbidity. J Thorac Cardiovasc Surg (2013) 0.88
Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery. Crit Care (2014) 0.87
Advanced thoracoscopic procedures are facilitated by computer-aided robotic technology. Eur J Cardiothorac Surg (2003) 0.87
Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. JACC Cardiovasc Interv (2010) 0.86
Radiofrequency and microwave energy sources in surgical ablation of atrial fibrillation: a comparative analysis. Heart Surg Forum (2006) 0.85
A prospective, double-blind, randomized, placebo-controlled study of dexmedetomidine as an adjunct to epidural analgesia after thoracic surgery. J Cardiothorac Vasc Anesth (2005) 0.85
Alternative energy sources for surgical atrial ablation. J Card Surg (2004) 0.85
Device exchange in HeartMate II recipients: long-term outcomes and risk of thrombosis recurrence. ASAIO J (2015) 0.84
New technology for surgical coronary revascularization. Circulation (2006) 0.83
Clinical indication for use and outcomes after inhaled nitric oxide therapy. Ann Thorac Surg (2006) 0.83
Eight-year experience with minimally invasive cardiothoracic surgery. World J Surg (2010) 0.83
An original model to predict Intensive Care Unit length-of stay after cardiac surgery in a competing risk framework. Int J Cardiol (2012) 0.83
Surgical revision after percutaneous mitral valve repair with a clip: initial multicenter experience. Ann Thorac Surg (2005) 0.83
Retroperitoneal hematoma with abdominal compartment syndrome during minimally invasive mitral valve replacement. Ann Thorac Surg (2010) 0.83
The spindle positioning protein Kar9p interacts with the sumoylation machinery in Saccharomyces cerevisiae. Genetics (2008) 0.82
The Surgical Procedure Assessment (SPA) score predicts intensive care unit length of stay after cardiac surgery. J Thorac Cardiovasc Surg (2011) 0.81
Robotic valve surgery: how does the future look? Adv Cardiol (2004) 0.81
Minimally invasive versus standard approach for excision of atrial masses. Heart Surg Forum (2007) 0.81
Combining stem cells and tissue engineering in cardiovascular repair -- a step forward to derivation of novel implants with enhanced function and self-renewal characteristics. Recent Pat Cardiovasc Drug Discov (2012) 0.81
Microwave ablation for surgical treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg (2002) 0.80
On-pump versus off-pump surgical revascularization in patients with acute coronary syndromes: analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial. J Thorac Cardiovasc Surg (2011) 0.80
Acute kidney injury after cardiac surgery: does the time interval from contrast administration to surgery matter? J Cardiothorac Vasc Anesth (2012) 0.79
High-dose remifentanil does not impair cerebrovascular carbon dioxide reactivity in healthy male volunteers. Anesthesiology (2003) 0.79
The use of methylene blue for vasodilatory shock in a pediatric lung transplant patient. J Cardiothorac Vasc Anesth (2009) 0.79
Changes in physician reimbursement by medicare for critical care services from 1998 to 2008. Am J Respir Crit Care Med (2013) 0.79
Off-pump epicardial atrial fibrillation surgery utilizing a novel bipolar radiofrequency system. Heart Surg Forum (2006) 0.79
Robot-assisted off-pump minimally invasive reoperative coronary artery bypass grafting: case report. Heart Surg Forum (2004) 0.78
Hepatic and renal protection during cardiac surgery. Anesthesiol Clin (2008) 0.78
Thoracoscopic epicardial pulmonary vein ablation for lone paroxysmal atrial fibrillation. Europace (2005) 0.78
Minimally invasive surgery for atrial fibrillation: toward a totally endoscopic, beating heart approach. J Card Surg (2004) 0.77
Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial. J Am Coll Cardiol (2012) 0.77
Patient-specific characteristics determine success of surgical atrial fibrillation ablation in patients with persistent atrial fibrillation. Heart Surg Forum (2007) 0.77
Surgical ablation of atrial fibrillation: the Columbia Presbyterian experience. J Card Surg (2006) 0.77
Ability to induce atrial fibrillation in the peri-operative period is associated with phosphorylation-dependent inhibition of TWIK protein-related acid-sensitive potassium channel 1 (TASK-1). J Biol Chem (2012) 0.77
Pathological healing response of explanted MitraClip devices. Circulation (2011) 0.77
Longer duration of continuous-flow ventricular assist device support predicts greater hemodynamic compromise after return of pulsatility. J Thorac Cardiovasc Surg (2008) 0.76
Thoracoscopic lobectomy using robotic technology. Heart Surg Forum (2003) 0.76
Bridging to transplantation with left ventricular assist devices: outcomes in patients aged 60 years and older. J Thorac Cardiovasc Surg (2005) 0.76
Heart and lung transplantation. Curr Opin Anaesthesiol (2014) 0.76
Assessment of a new experimental model of isolated right ventricular failure. Artif Organs (2010) 0.75
The authors reply. Crit Care Med (2015) 0.75
Severe sepsis: a bundle still under construction? Can J Anaesth (2007) 0.75
Blood transfusion and cardiac surgery. JAMA (2011) 0.75
Chronic kidney disease: the silent enemy? Anesth Analg (2011) 0.75
Reply to Drs Rady and Verheijde. J Cardiothorac Vasc Anesth (2012) 0.75
Surgical Ablation for Atrial Fibrillation. N Engl J Med (2015) 0.75
A new pulsatile volumetric device with biomorphic valves for the in vitro study of the cardiovascular system. Artif Organs (2011) 0.75
Efficacy of the "box" lesion pattern in the treatment of atrial fibrillation in the presence of mitral valve disease. Ann Thorac Surg (2004) 0.75